Search Results 1391-1400 of 19369 for hemoglobin

  1. Sunitinib Malate with or without Gemcitabine Hydrochloride in Treating Patients with Advanced Kidney Cancer that Cannot be Removed by Surgery - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL (transfusions allowed); Serum creatinine clearance ≥ 30 mL/min; SGOT and SGPT ≤ 2.5 times ULN (≤ 5 times ULN in the presence of ...

  2. A Study to Evaluate RGLS4326 to Treat Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Hemoglobin > 12 g/dL for females and > 13.5 g/dL for males;; Total and direct bilirubin < 1.5 x upper limit of normal (ULN), unless elevated bilirubin is ...

  3. A Study to Evaluate Aspirin for Treating Multiple Sclerosis-related Fatigue - Mayo Clinic

    Participation eligibility · Positive pregnancy test; · Hemoglobin less than 11.0 g/dL (women) or 13.0 g/dL (men); · Platelet count < 120,000/μL; · Serum creatinine ...

  4. Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer - Mayo Clinic

    Hemoglobin ≥ 9 g/dL (pre-registration cycle). Total bilirubin ≤ 1.5 x upper limit of normal (ULN) (pre-registration cycle). Aspartate aminotransferase ...

  5. Leucovorin (intramuscular route, intravenous route) - Side effects & uses - Mayo Clinic

    Leucovorin injection is used as a rescue after high-dose methotrexate treatment. This medicine is also used to lessen the toxic effects of methotrexate in ...

  6. A Study Using the New TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients with Metastatic, Persistent, Recurrent, or Progressive Solid Tumors - Mayo Clinic

    Hemoglobin >= 10 g/dL; Total bilirubin =< 1.5 X upper limit of normal (ULN) unless history of Gilbert's syndrome documented prior to first-line treatment of ...

  7. A Study of AbGn-107 in Patients With Gastric, Colorectal, or Pancreatic Cancer - Mayo Clinic

    Hemoglobin ≥9 g/dL,; Platelet count ≥100 x 109/L,; Serum creatinine ≤1.5 x upper limit of normal (ULN) or a calculated creatinine clearance >60 mL/min ...

  8. Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment - Mayo Clinic

    - Hemoglobin ≥ 10 g/dL. - Total bilirubin ≤ 2 x institutional upper limit of normal (ULN). - Aspartate aminotransferase (AST) serum glutamic oxaloacetic ...

  9. Arthritis Clinical Trials

    We will collect both non-invasive hemoglobin and conventional serum hemoglobin labs from patients postoperatively following outpatient total joint ...

  10. Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery - Mayo Clinic

    Hemoglobin (Hgb) ≥ 9.0 g/dL obtained ≤ 7 days prior to registration; International normalized ratio (INR) and partial thromboplastin (PTT) ≤ 3.0 x ULN ...